Track topics on Twitter Track topics that are important to you
HERNDON, Va., July 21, 2015 (GLOBE NEWSWIRE) -- K12 Inc. (NYSE:LRN) announced today it plans to host a conference call to discuss fourth quarter and full fiscal year 2015 financial results during a conference call scheduled for Tuesday, August 4, 2015 at 8:30 a.m. eastern time (ET).
A live webcast of the call will be available at http://public.viavid.com/index.php?id=115414. To participate in the live call, investors and analysts should dial (877) 407-4019 (domestic) or (201) 689-8337 (international) at 8:15 a.m. (ET). No passcode is required. Please access the web site at least 15 minutes prior to the start of the call.
A replay of the call will be available starting on August 4, 2015 at 11:00 a.m. ET through September 4, 2015 at 11:00 a.m. ET, at (877) 660-6853 (domestic) or (201) 612-7415 (international) using conference ID 13614346. A webcast replay of the call will be available at http://public.viavid.com/index.php?id=115414 for 30 days.
About K12 Inc.
K12 Inc. (NYSE:LRN) is driving innovation and advancing the quality of education by delivering state-of-the-art, digital learning platforms and technology to students and school districts across the globe. K12's award winning curriculum serves over 2,000 schools and school districts and has delivered more than four million courses over the past decade. K12 is a company of educators with the nation's largest network of K-12 online school teachers, providing instruction, academic services, and learning solutions to public schools and districts, traditional classrooms, blended school programs, and directly to families. The K12program is offered through K12 partner public schools in approximately two-thirds of the states and the District of Columbia, and through private schools serving students in all 50 states and more than 100 countries. More information can be found at K12.com.
CONTACT: K12 Inc. Investor Contact: Mike Kraft, 571-353-7778 VP Finance & Corporate Treasurer email@example.com or Press Contact: Frank Giancamilli, 703-483-1529 Senior Manager Corporate Communications firstname.lastname@example.orgNEXT ARTICLE
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...